SlideShare une entreprise Scribd logo
1  sur  45
Télécharger pour lire hors ligne
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 11
Smoking Related ILDSmoking Related ILD
Amr Badreldin HamdyAmr Badreldin Hamdy
MD, FCCPMD, FCCP
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 22
They represent aThey represent a
heterogeneous group ofheterogeneous group of
lung disorders, generallylung disorders, generally
characterized bycharacterized by
dyspnea, dry cough,dyspnea, dry cough,
diffuse interstitialdiffuse interstitial
infiltrates, restrictive lunginfiltrates, restrictive lung
function pattern, andfunction pattern, and
impaired gas exchange.impaired gas exchange.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 33
The majority of ILDThe majority of ILD
are of unknownare of unknown
cause, and knowncause, and known
causes includecauses include
gases, fumes, drugs,gases, fumes, drugs,
radiation, infections,radiation, infections,
inorganic dusts…etc.inorganic dusts…etc.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 44
ILD positively associatedILD positively associated
with smoking:with smoking:
1. UIP/idiopathic pulmonary fibrosis.1. UIP/idiopathic pulmonary fibrosis.
2. Desquamative interstitial2. Desquamative interstitial
pneumonia.pneumonia.
3. Respiratory bronchiolitis-3. Respiratory bronchiolitis-
associated interstitial lung disease.associated interstitial lung disease.
4. Pulmonary Langerhan’s cell4. Pulmonary Langerhan’s cell
histiocytosis.histiocytosis.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 55
Respiratory bronchiolitisRespiratory bronchiolitis
is extremely common inis extremely common in
cigarette smokerscigarette smokers
(smoker’s bronchiolitis).(smoker’s bronchiolitis).
Bronchiolitis is a genericBronchiolitis is a generic
term used clinically toterm used clinically to
describe variousdescribe various
inflammatory diseases ofinflammatory diseases of
small airways.small airways.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 66
It usually occursIt usually occurs
without symptoms orwithout symptoms or
significant interstitialsignificant interstitial
lung disease.lung disease.
It may account forIt may account for
sub-clinical radiologicalsub-clinical radiological
changes in up to onechanges in up to one
fifth of smokers.fifth of smokers.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 77
Although respiratoryAlthough respiratory
bronchiolitis occurs inbronchiolitis occurs in
virtually all smokers itvirtually all smokers it
is of little clinicalis of little clinical
significance in the vastsignificance in the vast
majority of cases.majority of cases.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 88
ILD negativelyILD negatively
associated withassociated with
smokingsmoking::
1. Hypersensitivity1. Hypersensitivity
pneumonitispneumonitis
(exogenous allergic(exogenous allergic
alveolitis).alveolitis).
2. Sarcoidosis.2. Sarcoidosis.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 99
1.1.
Occupational/Environmental.Occupational/Environmental.
2. Granulomatous diseases.2. Granulomatous diseases.
3. Iatrogenic/drug induced.3. Iatrogenic/drug induced.
4. Collagen-vascular4. Collagen-vascular
diseases.diseases.
5. Inherited.5. Inherited.
6. Unique entities.6. Unique entities.
7. Idiopathic interstitial7. Idiopathic interstitial
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1010
Without a completeWithout a complete
thorough clinicalthorough clinical
evaluation, all ILDevaluation, all ILD
are of unknownare of unknown
causecause..
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1111
IdiopathicIdiopathic
Pulmonary FibrosisPulmonary Fibrosis
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1212
The role of smoking inThe role of smoking in
the pathogenesis of IPF isthe pathogenesis of IPF is
controversial. It appearscontroversial. It appears
to increase the risk ofto increase the risk of
development of IPF, butdevelopment of IPF, but
there is no evidence thatthere is no evidence that
smoking per se directlysmoking per se directly
leads to the developmentleads to the development
of IPF.of IPF.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1313
Usually sporadic or familial.Usually sporadic or familial.
Male to female ratio 2 to one.Male to female ratio 2 to one.
Bilateral reticular orBilateral reticular or
reticular-nodular opacitiesreticular-nodular opacities
with small lung volumes.with small lung volumes.
Typically lower zone andTypically lower zone and
peripheral predominance inperipheral predominance in
the distribution.the distribution.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1414
HRCT showsHRCT shows
irregular linearirregular linear
opacities andopacities and
honeycombing,honeycombing,
predominantly in thepredominantly in the
base and sub-pleuralbase and sub-pleural
lung.lung.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1515
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1616
PFT usuallyPFT usually
demonstrates ademonstrates a
restrictive defect withrestrictive defect with
reduced lung volumesreduced lung volumes
and diffusing capacity.and diffusing capacity.
Exercise-induced de-Exercise-induced de-
saturation is almostsaturation is almost
always seen.always seen.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1717
In patients with pre-existingIn patients with pre-existing
emphysema, the lungemphysema, the lung
volumes and flow rates mayvolumes and flow rates may
be normal due tobe normal due to
counteracting physiologicalcounteracting physiological
effects of emphysema andeffects of emphysema and
fibrosis.fibrosis.
In such patients, PFT mayIn such patients, PFT may
only reveal a severelyonly reveal a severely
reduced diffusing capacityreduced diffusing capacity..
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1818
DesquamativeDesquamative
Interstitial PneumoniaInterstitial Pneumonia
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1919
Ninety percent areNinety percent are
smokers or ex-smokers.smokers or ex-smokers.
May occasionally beMay occasionally be
seen in association withseen in association with
systemic disorders orsystemic disorders or
infections, as well asinfections, as well as
exposure toexposure to
occupational/environmentoccupational/environment
al agents and drugs.al agents and drugs.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2020
Average age of onset isAverage age of onset is
40 years.40 years.
Male predominance (2:1).Male predominance (2:1).
Inspiratory crackles areInspiratory crackles are
heard in 60%.heard in 60%.
Digital clubbing in nearlyDigital clubbing in nearly
50%.50%.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2121
On chest X-ray lungOn chest X-ray lung
volume appearsvolume appears
reduced unless therereduced unless there
is co-existent OADis co-existent OAD
such as smokerssuch as smokers
with emphysema.with emphysema.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2222
Predominant finding byPredominant finding by
HRCT is the presence ofHRCT is the presence of
areas of ground-glassareas of ground-glass
attenuations, typicallyattenuations, typically
sub-pleural and lowersub-pleural and lower
lung zone predominance.lung zone predominance.
Honeycombing is usuallyHoneycombing is usually
not present.not present.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2323
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2424
R-BILDR-BILD
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2525
It is a clinicalIt is a clinical
pathological entity seenpathological entity seen
almost exclusively inalmost exclusively in
current or formercurrent or former
smokers.smokers.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2626
PFT may be normal, butPFT may be normal, but
more commonly show amore commonly show a
mixed obstructive-restrictivemixed obstructive-restrictive
pattern of a mild-to-pattern of a mild-to-
moderate degree.moderate degree.
Reduced diffusing capacityReduced diffusing capacity
is common.is common.
TLC may be normal, mildlyTLC may be normal, mildly
increased or mildly reduced.increased or mildly reduced.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2727
Diffuse, fine reticular orDiffuse, fine reticular or
reticular-nodular opacitiesreticular-nodular opacities
are present in more thanare present in more than
2/3.2/3.
Ground-glass pattern mayGround-glass pattern may
be the predominantbe the predominant
abnormality.abnormality.
There is no honeycombingThere is no honeycombing
(DD IPF).(DD IPF).
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2828
Areas of ground-glassAreas of ground-glass
attenuation are theattenuation are the
most common findingmost common finding
((smoker’s alveolitissmoker’s alveolitis ).).
Micro-nodules may beMicro-nodules may be
present ( = respiratorypresent ( = respiratory
bronchiolitis).bronchiolitis).
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2929
Pulmonary Langerhan’sPulmonary Langerhan’s
Cell HistiocytosisCell Histiocytosis
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3030
The isolated pulmonaryThe isolated pulmonary
form in adults occursform in adults occurs
almost exclusively inalmost exclusively in
cigarette smokers. Adultcigarette smokers. Adult
PLCH represents aPLCH represents a
polyclonal, reactivepolyclonal, reactive
disorder triggered bydisorder triggered by
cigarette smoking.cigarette smoking.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3131
Most patients are young adults (30-Most patients are young adults (30-
40y).40y).
Sex distribution is equal.Sex distribution is equal.
Ninety or more are current orNinety or more are current or
previous cigarette smokers.previous cigarette smokers.
The bronchiolar distribution ofThe bronchiolar distribution of
pathological lesions is consistentpathological lesions is consistent
with the possibility that an inhaledwith the possibility that an inhaled
antigen is involved in theantigen is involved in the
pathogenesis of this disorder.pathogenesis of this disorder.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3232
Physical examinationPhysical examination
frequently normal.frequently normal.
Cystic bone lesionsCystic bone lesions
in 10% (skull, ribs,in 10% (skull, ribs,
pelvis).pelvis).
Diabetes insipidus inDiabetes insipidus in
10%.10%.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3333
PFT show bothPFT show both
obstructive and restrictiveobstructive and restrictive
changes (effects fromchanges (effects from
cigarette smoking may becigarette smoking may be
superimposed andsuperimposed and
difficult to distinguishdifficult to distinguish
from effects of PLCHfrom effects of PLCH
itself).itself).
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3434
Typical finding on CXRTypical finding on CXR
include nodular orinclude nodular or
reticular-nodular opacitiesreticular-nodular opacities
most prominent in themost prominent in the
middle and upper lungmiddle and upper lung
zones, usually sparing ofzones, usually sparing of
the costo-phrenic anglesthe costo-phrenic angles
Lung volumes appearLung volumes appear
normal or increased.normal or increased.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3535
HRCT show thin-HRCT show thin-
walled cysts, noduleswalled cysts, nodules
(with or without(with or without
cavitation) or acavitation) or a
combination of nodulescombination of nodules
and cysts.and cysts.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3636
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3737
PrognosisPrognosis
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3838
IPFIPF
Response toResponse to
steroids is poor.steroids is poor.
Prognosis is poorPrognosis is poor
with no possibility ofwith no possibility of
complete recovery.complete recovery.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3939
DIPDIP
Most patients remainMost patients remain
stable or improve withstable or improve with
corticosteroid therapycorticosteroid therapy
and complete recoveryand complete recovery
is possible.is possible.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4040
R-BILDR-BILD
Good prognosis,Good prognosis,
particularly with smokingparticularly with smoking
cessation.cessation.
Good response toGood response to
corticosteroid therapy andcorticosteroid therapy and
complete recovery iscomplete recovery is
possiblepossible..
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4141
PLCHPLCH
Smoking cessation maySmoking cessation may
prevent progression of theprevent progression of the
disease.disease.
Response to steroids isResponse to steroids is
fair.fair.
Complete recovery isComplete recovery is
possible.possible.
Prognosis is good.Prognosis is good.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4242
ConclusionConclusion
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4343
• Smoking history is important inSmoking history is important in
ILD.ILD.
• Quitting smoking is importantQuitting smoking is important
in ILD.in ILD.
• ILD may accompany COPD.ILD may accompany COPD.
• HRCT may be of help inHRCT may be of help in
patients with COPD notpatients with COPD not
responding to usual broncho-responding to usual broncho-
dilator therapy. They may needdilator therapy. They may need
to add corticosteroids to theirto add corticosteroids to their
regimens.regimens.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4444
• This may explain why soThis may explain why so
many patients with COPDmany patients with COPD
need corticosteroids inneed corticosteroids in
their treatment protocol.their treatment protocol.
• The incidence ofThe incidence of
smoking in the smokingsmoking in the smoking
related ILD reaches 90%,related ILD reaches 90%,
the same incidence as forthe same incidence as for
COPD.COPD.
06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4545
THANK YOUTHANK YOU

Contenu connexe

Similaire à Smoking Related Interstitial Lung Diseases

Sarcoidosis & orphan lung disease
Sarcoidosis & orphan lung diseaseSarcoidosis & orphan lung disease
Sarcoidosis & orphan lung diseaseimangalal
 
Interstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesInterstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesmeducationdotnet
 
Cirrhosis and portal hypertension in children
Cirrhosis and portal hypertension in childrenCirrhosis and portal hypertension in children
Cirrhosis and portal hypertension in childrenLm Huq
 
Dr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptDr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptINDRANIL DUTTA
 
CASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionCASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionsarita pandey
 
laryngomalacia-220520053359-7b8c2146.pptx
laryngomalacia-220520053359-7b8c2146.pptxlaryngomalacia-220520053359-7b8c2146.pptx
laryngomalacia-220520053359-7b8c2146.pptxDrAnitaDavidDeptofPa
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseimangalal
 
Age related macular degeneration (
Age related macular degeneration ( Age related macular degeneration (
Age related macular degeneration ( Kshitij Sharma
 
Asthma control (2)
Asthma control (2)Asthma control (2)
Asthma control (2)amr hamdy
 
Acs0624 Raynaud Phenomenon
Acs0624 Raynaud PhenomenonAcs0624 Raynaud Phenomenon
Acs0624 Raynaud Phenomenonmedbookonline
 
VENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVikas Kumar
 

Similaire à Smoking Related Interstitial Lung Diseases (15)

Sarcoidosis & orphan lung disease
Sarcoidosis & orphan lung diseaseSarcoidosis & orphan lung disease
Sarcoidosis & orphan lung disease
 
Leprosy, Indian scenario
Leprosy, Indian scenarioLeprosy, Indian scenario
Leprosy, Indian scenario
 
Suffocation
SuffocationSuffocation
Suffocation
 
Interstitial and restrictive lung diseases
Interstitial and restrictive lung diseasesInterstitial and restrictive lung diseases
Interstitial and restrictive lung diseases
 
Cirrhosis and portal hypertension in children
Cirrhosis and portal hypertension in childrenCirrhosis and portal hypertension in children
Cirrhosis and portal hypertension in children
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Dr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly pptDr Indranil Dutta vascular anomaly ppt
Dr Indranil Dutta vascular anomaly ppt
 
CASE presentation & TOPIC discussion
CASE presentation & TOPIC discussionCASE presentation & TOPIC discussion
CASE presentation & TOPIC discussion
 
laryngomalacia-220520053359-7b8c2146.pptx
laryngomalacia-220520053359-7b8c2146.pptxlaryngomalacia-220520053359-7b8c2146.pptx
laryngomalacia-220520053359-7b8c2146.pptx
 
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease
Chronic obstructive pulmonary disease
 
Age related macular degeneration (
Age related macular degeneration ( Age related macular degeneration (
Age related macular degeneration (
 
Asthma control (2)
Asthma control (2)Asthma control (2)
Asthma control (2)
 
Acs0624 Raynaud Phenomenon
Acs0624 Raynaud PhenomenonAcs0624 Raynaud Phenomenon
Acs0624 Raynaud Phenomenon
 
VENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECTVENTRICULAR SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECT
 
Pharmacotherapy of Asthma
Pharmacotherapy of AsthmaPharmacotherapy of Asthma
Pharmacotherapy of Asthma
 

Dernier

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 

Dernier (20)

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 

Smoking Related Interstitial Lung Diseases

  • 1. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 11 Smoking Related ILDSmoking Related ILD Amr Badreldin HamdyAmr Badreldin Hamdy MD, FCCPMD, FCCP
  • 2. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 22 They represent aThey represent a heterogeneous group ofheterogeneous group of lung disorders, generallylung disorders, generally characterized bycharacterized by dyspnea, dry cough,dyspnea, dry cough, diffuse interstitialdiffuse interstitial infiltrates, restrictive lunginfiltrates, restrictive lung function pattern, andfunction pattern, and impaired gas exchange.impaired gas exchange.
  • 3. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 33 The majority of ILDThe majority of ILD are of unknownare of unknown cause, and knowncause, and known causes includecauses include gases, fumes, drugs,gases, fumes, drugs, radiation, infections,radiation, infections, inorganic dusts…etc.inorganic dusts…etc.
  • 4. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 44 ILD positively associatedILD positively associated with smoking:with smoking: 1. UIP/idiopathic pulmonary fibrosis.1. UIP/idiopathic pulmonary fibrosis. 2. Desquamative interstitial2. Desquamative interstitial pneumonia.pneumonia. 3. Respiratory bronchiolitis-3. Respiratory bronchiolitis- associated interstitial lung disease.associated interstitial lung disease. 4. Pulmonary Langerhan’s cell4. Pulmonary Langerhan’s cell histiocytosis.histiocytosis.
  • 5. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 55 Respiratory bronchiolitisRespiratory bronchiolitis is extremely common inis extremely common in cigarette smokerscigarette smokers (smoker’s bronchiolitis).(smoker’s bronchiolitis). Bronchiolitis is a genericBronchiolitis is a generic term used clinically toterm used clinically to describe variousdescribe various inflammatory diseases ofinflammatory diseases of small airways.small airways.
  • 6. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 66 It usually occursIt usually occurs without symptoms orwithout symptoms or significant interstitialsignificant interstitial lung disease.lung disease. It may account forIt may account for sub-clinical radiologicalsub-clinical radiological changes in up to onechanges in up to one fifth of smokers.fifth of smokers.
  • 7. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 77 Although respiratoryAlthough respiratory bronchiolitis occurs inbronchiolitis occurs in virtually all smokers itvirtually all smokers it is of little clinicalis of little clinical significance in the vastsignificance in the vast majority of cases.majority of cases.
  • 8. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 88 ILD negativelyILD negatively associated withassociated with smokingsmoking:: 1. Hypersensitivity1. Hypersensitivity pneumonitispneumonitis (exogenous allergic(exogenous allergic alveolitis).alveolitis). 2. Sarcoidosis.2. Sarcoidosis.
  • 9. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 99 1.1. Occupational/Environmental.Occupational/Environmental. 2. Granulomatous diseases.2. Granulomatous diseases. 3. Iatrogenic/drug induced.3. Iatrogenic/drug induced. 4. Collagen-vascular4. Collagen-vascular diseases.diseases. 5. Inherited.5. Inherited. 6. Unique entities.6. Unique entities. 7. Idiopathic interstitial7. Idiopathic interstitial
  • 10. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1010 Without a completeWithout a complete thorough clinicalthorough clinical evaluation, all ILDevaluation, all ILD are of unknownare of unknown causecause..
  • 11. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1111 IdiopathicIdiopathic Pulmonary FibrosisPulmonary Fibrosis
  • 12. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1212 The role of smoking inThe role of smoking in the pathogenesis of IPF isthe pathogenesis of IPF is controversial. It appearscontroversial. It appears to increase the risk ofto increase the risk of development of IPF, butdevelopment of IPF, but there is no evidence thatthere is no evidence that smoking per se directlysmoking per se directly leads to the developmentleads to the development of IPF.of IPF.
  • 13. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1313 Usually sporadic or familial.Usually sporadic or familial. Male to female ratio 2 to one.Male to female ratio 2 to one. Bilateral reticular orBilateral reticular or reticular-nodular opacitiesreticular-nodular opacities with small lung volumes.with small lung volumes. Typically lower zone andTypically lower zone and peripheral predominance inperipheral predominance in the distribution.the distribution.
  • 14. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1414 HRCT showsHRCT shows irregular linearirregular linear opacities andopacities and honeycombing,honeycombing, predominantly in thepredominantly in the base and sub-pleuralbase and sub-pleural lung.lung.
  • 15. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1515
  • 16. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1616 PFT usuallyPFT usually demonstrates ademonstrates a restrictive defect withrestrictive defect with reduced lung volumesreduced lung volumes and diffusing capacity.and diffusing capacity. Exercise-induced de-Exercise-induced de- saturation is almostsaturation is almost always seen.always seen.
  • 17. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1717 In patients with pre-existingIn patients with pre-existing emphysema, the lungemphysema, the lung volumes and flow rates mayvolumes and flow rates may be normal due tobe normal due to counteracting physiologicalcounteracting physiological effects of emphysema andeffects of emphysema and fibrosis.fibrosis. In such patients, PFT mayIn such patients, PFT may only reveal a severelyonly reveal a severely reduced diffusing capacityreduced diffusing capacity..
  • 18. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1818 DesquamativeDesquamative Interstitial PneumoniaInterstitial Pneumonia
  • 19. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 1919 Ninety percent areNinety percent are smokers or ex-smokers.smokers or ex-smokers. May occasionally beMay occasionally be seen in association withseen in association with systemic disorders orsystemic disorders or infections, as well asinfections, as well as exposure toexposure to occupational/environmentoccupational/environment al agents and drugs.al agents and drugs.
  • 20. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2020 Average age of onset isAverage age of onset is 40 years.40 years. Male predominance (2:1).Male predominance (2:1). Inspiratory crackles areInspiratory crackles are heard in 60%.heard in 60%. Digital clubbing in nearlyDigital clubbing in nearly 50%.50%.
  • 21. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2121 On chest X-ray lungOn chest X-ray lung volume appearsvolume appears reduced unless therereduced unless there is co-existent OADis co-existent OAD such as smokerssuch as smokers with emphysema.with emphysema.
  • 22. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2222 Predominant finding byPredominant finding by HRCT is the presence ofHRCT is the presence of areas of ground-glassareas of ground-glass attenuations, typicallyattenuations, typically sub-pleural and lowersub-pleural and lower lung zone predominance.lung zone predominance. Honeycombing is usuallyHoneycombing is usually not present.not present.
  • 23. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2323
  • 24. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2424 R-BILDR-BILD
  • 25. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2525 It is a clinicalIt is a clinical pathological entity seenpathological entity seen almost exclusively inalmost exclusively in current or formercurrent or former smokers.smokers.
  • 26. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2626 PFT may be normal, butPFT may be normal, but more commonly show amore commonly show a mixed obstructive-restrictivemixed obstructive-restrictive pattern of a mild-to-pattern of a mild-to- moderate degree.moderate degree. Reduced diffusing capacityReduced diffusing capacity is common.is common. TLC may be normal, mildlyTLC may be normal, mildly increased or mildly reduced.increased or mildly reduced.
  • 27. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2727 Diffuse, fine reticular orDiffuse, fine reticular or reticular-nodular opacitiesreticular-nodular opacities are present in more thanare present in more than 2/3.2/3. Ground-glass pattern mayGround-glass pattern may be the predominantbe the predominant abnormality.abnormality. There is no honeycombingThere is no honeycombing (DD IPF).(DD IPF).
  • 28. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2828 Areas of ground-glassAreas of ground-glass attenuation are theattenuation are the most common findingmost common finding ((smoker’s alveolitissmoker’s alveolitis ).). Micro-nodules may beMicro-nodules may be present ( = respiratorypresent ( = respiratory bronchiolitis).bronchiolitis).
  • 29. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 2929 Pulmonary Langerhan’sPulmonary Langerhan’s Cell HistiocytosisCell Histiocytosis
  • 30. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3030 The isolated pulmonaryThe isolated pulmonary form in adults occursform in adults occurs almost exclusively inalmost exclusively in cigarette smokers. Adultcigarette smokers. Adult PLCH represents aPLCH represents a polyclonal, reactivepolyclonal, reactive disorder triggered bydisorder triggered by cigarette smoking.cigarette smoking.
  • 31. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3131 Most patients are young adults (30-Most patients are young adults (30- 40y).40y). Sex distribution is equal.Sex distribution is equal. Ninety or more are current orNinety or more are current or previous cigarette smokers.previous cigarette smokers. The bronchiolar distribution ofThe bronchiolar distribution of pathological lesions is consistentpathological lesions is consistent with the possibility that an inhaledwith the possibility that an inhaled antigen is involved in theantigen is involved in the pathogenesis of this disorder.pathogenesis of this disorder.
  • 32. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3232 Physical examinationPhysical examination frequently normal.frequently normal. Cystic bone lesionsCystic bone lesions in 10% (skull, ribs,in 10% (skull, ribs, pelvis).pelvis). Diabetes insipidus inDiabetes insipidus in 10%.10%.
  • 33. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3333 PFT show bothPFT show both obstructive and restrictiveobstructive and restrictive changes (effects fromchanges (effects from cigarette smoking may becigarette smoking may be superimposed andsuperimposed and difficult to distinguishdifficult to distinguish from effects of PLCHfrom effects of PLCH itself).itself).
  • 34. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3434 Typical finding on CXRTypical finding on CXR include nodular orinclude nodular or reticular-nodular opacitiesreticular-nodular opacities most prominent in themost prominent in the middle and upper lungmiddle and upper lung zones, usually sparing ofzones, usually sparing of the costo-phrenic anglesthe costo-phrenic angles Lung volumes appearLung volumes appear normal or increased.normal or increased.
  • 35. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3535 HRCT show thin-HRCT show thin- walled cysts, noduleswalled cysts, nodules (with or without(with or without cavitation) or acavitation) or a combination of nodulescombination of nodules and cysts.and cysts.
  • 36. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3636
  • 37. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3737 PrognosisPrognosis
  • 38. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3838 IPFIPF Response toResponse to steroids is poor.steroids is poor. Prognosis is poorPrognosis is poor with no possibility ofwith no possibility of complete recovery.complete recovery.
  • 39. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 3939 DIPDIP Most patients remainMost patients remain stable or improve withstable or improve with corticosteroid therapycorticosteroid therapy and complete recoveryand complete recovery is possible.is possible.
  • 40. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4040 R-BILDR-BILD Good prognosis,Good prognosis, particularly with smokingparticularly with smoking cessation.cessation. Good response toGood response to corticosteroid therapy andcorticosteroid therapy and complete recovery iscomplete recovery is possiblepossible..
  • 41. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4141 PLCHPLCH Smoking cessation maySmoking cessation may prevent progression of theprevent progression of the disease.disease. Response to steroids isResponse to steroids is fair.fair. Complete recovery isComplete recovery is possible.possible. Prognosis is good.Prognosis is good.
  • 42. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4242 ConclusionConclusion
  • 43. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4343 • Smoking history is important inSmoking history is important in ILD.ILD. • Quitting smoking is importantQuitting smoking is important in ILD.in ILD. • ILD may accompany COPD.ILD may accompany COPD. • HRCT may be of help inHRCT may be of help in patients with COPD notpatients with COPD not responding to usual broncho-responding to usual broncho- dilator therapy. They may needdilator therapy. They may need to add corticosteroids to theirto add corticosteroids to their regimens.regimens.
  • 44. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4444 • This may explain why soThis may explain why so many patients with COPDmany patients with COPD need corticosteroids inneed corticosteroids in their treatment protocol.their treatment protocol. • The incidence ofThe incidence of smoking in the smokingsmoking in the smoking related ILD reaches 90%,related ILD reaches 90%, the same incidence as forthe same incidence as for COPD.COPD.
  • 45. 06/26/1306/26/13 amr badreldin hamdyamr badreldin hamdy 4545 THANK YOUTHANK YOU